NCT04699838 Chemo-Immunotherapy Followed by Durvalumab and Ceralasertib in Treatment Naïve Patients With Extensive Stage Small Cell Lung Cancer Status RECRUITING Phase PHASE2
NCT04696692 Single-Cell Map of Immune and Lymphoma Cells in B-cell Non-Hodgkin's Lymphoma Status COMPLETED Phase NA
NCT04686773 Open-label, Non-randomized, Non-comparative, Phase II Study of Safety and Immunogenicity of Combination of AZD1222 and rAd26-S for COVID-19 Prevention Status COMPLETED Phase PHASE2
NCT04686604 PRagmatic Trial Of Messaging to Providers About Treatment of Heart Failure in the Inpatient Setting Status COMPLETED Phase NA
NCT04686591 Absolute Bioavailability and ADME Study of [14C]AZD9977 in Healthy Male Subjects Status COMPLETED Phase PHASE1
NCT04686305 Phase Ib Study of the Safety of T-DXd and Immunotherapy Agents With and Without Chemotherapy in Advanced or Metastatic HER2+, Non-squamous NSCLC Status RECRUITING Phase PHASE1
NCT04684446 Study in Adults of AZD1222 and rAd26-S Administered as Heterologous Prime-Boost Regimen for the Prevention of COVID-19 Status COMPLETED Phase PHASE1/PHASE2
NCT04676646 Study to Assess Efficacy and Safety of SZC for the Management of High Potassium in Patients With Symptomatic HFrEF Receiving Spironolactone Status COMPLETED Phase PHASE4
NCT04676477 HER3-DXd (Patritumab Deruxtecan; U3-1402) in Combination With Osimertinib in Subjects With Locally Advanced or Metastatic EGFR-mutated Non-Small Cell Lung Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT04675463 The Effects of Inhaled Budesonide-formoterol-glycopyrronium in Moderate-to-severe COPD Status UNKNOWN Phase NA
NCT04675034 A Study of the Efficacy and Safety of MEDI7352 in Participants With Painful Osteoarthritis of the Knee Status COMPLETED Phase PHASE2
NCT04675021 Absolute Bioavailability and ADME Study of Savolitinib in Healthy Male Subjects Status COMPLETED Phase PHASE1
NCT04673630 Study to Evaluate the Pharmacokinetics of Tezepelumab in Children With Asthma Status COMPLETED Phase PHASE1
NCT04667312 Observational Study of Durvalumab in Patients With Non-small-cell Lung Cancer in the United Kingdom Status COMPLETED Phase N/A
NCT04663100 Oral Adherence in Hematological Oncology Agents and Impact on Comorbid Therapy Adherence Status RECRUITING Phase NA
NCT04660045 Early Intervention With Acalabrutinib in Patients With High Risk CLL Status WITHDRAWN Phase PHASE2
NCT04656652 Study of DS-1062a Versus Docetaxel in Previously Treated Advanced or Metastatic Non-small Cell Lung Cancer With or Without Actionable Genomic Alterations (TROPION-LUNG01) Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT04655027 A Study to Investigate the Effect of Roxadustat Versus Recombinant Human Erythropoietin (rHuEPO) on Oral Iron Absorption in Chinese Patients With Anemia of Chronic Kidney Disease (CKD) Status COMPLETED Phase PHASE4
NCT04648839 Observational Retrospective Study on Clinical Outcomes of Patients Receiving Benralizumab in Spain. Status COMPLETED Phase N/A
NCT04646837 Mechanism of Response to IMFINZI Neoadjuvant Therapy in Non-small Cell Lung Cancer Patients Based on Multiple-omics Models Status UNKNOWN Phase PHASE1/PHASE2